Stock Scorecard
Stock Summary for Dexcom Inc (DXCM) - $84.51 as of 5/27/2025 12:39:12 PM EST
Total Score
7 out of 30
Safety Score
50 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for DXCM
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DXCM
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DXCM
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for DXCM
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for DXCM (50 out of 100)
Stock Price Rating (Max of 10) | 9 |
Historical Stock Price Rating (Max of 10) | 10 |
Stock Price Trend (Max of 10) | 2 |
Book Value (Max of 10) | 4 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 5 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 3 |
Trading Volume (Max of 10) | 10 |
Price to Earnings (Max of 10) | 2 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for DXCM
Financial Details for DXCM
Company Overview |
|
---|---|
Ticker | DXCM |
Company Name | Dexcom Inc |
Country | USA |
Description | DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 3/31/2025 |
Next Earnings Date | 7/23/2025 |
Stock Price History |
|
Last Day Price | 84.51 |
Price 4 Years Ago | 134.24 |
Last Day Price Updated | 5/27/2025 12:39:12 PM EST |
Last Day Volume | 2,599,356 |
Average Daily Volume | 4,060,338 |
52-Week High | 128.63 |
52-Week Low | 57.52 |
Last Price to 52 Week Low | 46.92% |
Valuation Measures |
|
Trailing PE | 63.54 |
Industry PE | 38.71 |
Sector PE | 39.78 |
5-Year Average PE | 111.89 |
Free Cash Flow Ratio | 36.58 |
Industry Free Cash Flow Ratio | 36.59 |
Sector Free Cash Flow Ratio | 31.33 |
Current Ratio Most Recent Quarter | 1.50 |
Total Cash Per Share | 2.31 |
Book Value Per Share Most Recent Quarter | 5.78 |
Price to Book Ratio | 14.62 |
Industry Price to Book Ratio | 5.03 |
Sector Price to Book Ratio | 31.86 |
Price to Sales Ratio Twelve Trailing Months | 7.99 |
Industry Price to Sales Ratio Twelve Trailing Months | 5.77 |
Sector Price to Sales Ratio Twelve Trailing Months | 39.43 |
Analyst Buy Ratings | 18 |
Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
Total Shares Outstanding | 392,107,000 |
Market Capitalization | 33,136,962,570 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.41% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -25.80% |
Annual Earnings Growth | 6.41% |
Reported EPS 12 Trailing Months | 1.33 |
Reported EPS Past Year | 0.32 |
Reported EPS Prior Year | 1.65 |
Net Income Twelve Trailing Months | 535,200,000 |
Net Income Past Year | 576,200,000 |
Net Income Prior Year | 541,500,000 |
Quarterly Revenue Growth YOY | 12.50% |
5-Year Revenue Growth | 22.27% |
Operating Margin Twelve Trailing Months | 12.90% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 904,900,000 |
Total Cash Past Year | 606,100,000 |
Total Cash Prior Year | 566,300,000 |
Net Cash Position Most Recent Quarter | -333,100,000 |
Net Cash Position Past Year | -630,900,000 |
Long Term Debt Past Year | 1,237,000,000 |
Long Term Debt Prior Year | 2,434,200,000 |
Total Debt Most Recent Quarter | 1,238,000,000 |
Equity to Debt Ratio Past Year | 0.63 |
Equity to Debt Ratio Most Recent Quarter | 0.65 |
Total Stockholder Equity Past Year | 2,102,600,000 |
Total Stockholder Equity Prior Year | 2,068,600,000 |
Total Stockholder Equity Most Recent Quarter | 2,266,600,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 575,200,000 |
Free Cash Flow Per Share Twelve Trailing Months | 1.47 |
Free Cash Flow Past Year | 630,700,000 |
Free Cash Flow Prior Year | 511,900,000 |
Options |
|
Put/Call Ratio | 0.31 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 3.64 |
MACD Signal | 3.69 |
20-Day Bollinger Lower Band | 61.43 |
20-Day Bollinger Middle Band | 79.23 |
20-Day Bollinger Upper Band | 97.03 |
Beta | 1.44 |
RSI | 58.94 |
50-Day SMA | 81.06 |
150-Day SMA | 101.56 |
200-Day SMA | 105.62 |
System |
|
Modified | 5/26/2025 10:33:06 PM EST |